Theranostics Health has appointed Luis Gutierrez president and CEO. Former CEO Glenn Hoke will remain with the company as executive VP and COO.
Gutierrez was previously executive VP and COO of Aptiv Solutions. Before that he was president of Covance's commercialization services division. He has also held management roles at Merck and MedAssurant.
Safeguard Scientifics has appointed Mara Aspinall to its board of directors. Aspinall formerly served as president and CEO of Ventana Medical Systems and global head of Roche Tissue Diagnostics. Prior to that she had founded and served as CEO of On-Q-ity, and she also previously was president of Genzyme Genetics and president of Genzyme Pharmaceuticals.
Former Life Technologies CEO and chairman Greg Lucier has joined the board of directors at Invuity, a medical device company based in San Francisco. Prior to Life Tech, Lucier held senior management positions at General Electric, most recently CEO and president of Medical Systems Information Technologies for GE Healthcare. He holds an MBA from Harvard Business School and has a BS in industrial engineering from Pennsylvania State University.
Vermillion has appointed Valerie Palmieri to the newly created position of COO.
Previously, Palmieri was president of Momentum Consulting, through which she has served as a strategic advisor to Vermillion for the past six months, helping the company launch Aspira Labs, its CLIA certified facility. Prior to that she was CEO of two healthcare start-ups, as well as national VP of anatomic pathology operations at LabCorp/Dianon.